Building Scalable Workforce Strategies in the Face of Industry Volatility to Retain Business-Critical Talent & Accelerate Your Early-Stage Biotech from Discovery to Development & Beyond

Designed for the CHRO / CPO / Head of HR at the Heart of Emerging Biopharma Organizations. 

 

As the equity-heavy biotech industry experiences one of the most volatile and turbulent markets to date, for those working in HR in these emerging biotech organizations, there is a need to rethink processes, turbocharge culture, and balance time acting as a strategic leader as well as delivering on business-critical benchmarks. 

Now in its third year,LEAP HR: Emerging Biopharma is the only forum dedicated to helping emerging life sciences organizations operating in the US break away from traditional HR processes to develop and establish a high-functioning HR function to drive business-critical innovation and scale. 

At LEAP HR: Emerging Biopharma, you will uncover 20+ case studies of how HR leaders are aligning with the business and building the high-impact strategies only fit for the emerging biopharma organizations seeking to accelerate growth and compete against life sciences giants. 

Why Experts are Attending LEAP

mary c

"LEAP HR: Emerging Biopharma exceeded my expectations - great content and collaborative participants! 10 out of 10."

Mary Campos, Vice President of Human Resources, TG Therapeutics

"There are lot of great HR conferences to select from today. However, LEAP HR: Emerging Biopharma is filling a gap in how to share innovative HR practices scaled appropriately from growing biotech companies."

Eric Fink, Executive Vice President & Chief Human Resources Officer, Global Blood Therapeutics

erik fink
ted h test

"LEAP HR: Emerging Biopharma will provide a unique experience to network with and learn from HR leaders in the biotech space. The relationships built at this conference can serve as a springboard for the rest of your career."

Ted Harding, Vice President of Human Resources, Jounce Therapeutics

20+ Case Studies to Maximise Your ROI

Sage Therapeutics

SAGE Therapeutics has created a scalable total talent ecosystem, combining internal and external resources, to drive growth and transition from an R&D to a commercial organization 

Dyno

Dyno Therapeutics has redefined its entire organizational structure in an unconventional way and in alignment with business strategy in order to accelerate through the next clinical inflection point 

alkermes logo

Alkermes is developing managers and leaders to be more thoughtful, empathetic, and compassionate to the issues that are going on in the world today to drive the future commercial success of the business 

immunogen

ImmunoGen was able to effectively stabilize and redeploy talent across its organization after a period of downsizing and find commercial success in the future 

FibroGen

FibroGen navigated multiple people priorities to ensure the realization of business outcomes and build an effective biotech US commercialization roadmap

Corium

Corium learned best practices and pitfalls to avoid as your organization transitions from R&D to commercial and the impact creating new company values had on the bottom line of the business